| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Functional Status of Elderly Adults before and after Initiation of Dialysis | New England Journal of Medicine | 2009 | 868 |
| 2 | Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia | JAMA - Journal of the American Medical Association | 2019 | 855 |
| 3 | The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis | Nephrology Dialysis Transplantation | 2011 | 502 |
| 4 | Renal Physiology of Pregnancy | Advances in Chronic Kidney Disease | 2013 | 463 |
| 5 | Effect of Homocysteine Lowering on Mortality and Vascular Disease in Advanced Chronic Kidney Disease and End-stage Renal Disease | JAMA - Journal of the American Medical Association | 2007 | 408 |
| 6 | Effects of Intensive BP Control in CKD | Journal of the American Society of Nephrology: JASN | 2017 | 386 |
| 7 | Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients | Critical Care | 2010 | 349 |
| 8 | COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium | American Journal of Transplantation | 2020 | 322 |
| 9 | Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions | JAMA - Journal of the American Medical Association | 2019 | 309 |
| 10 | Urinary excretion of viable podocytes in health and renal disease | American Journal of Physiology - Renal Physiology | 2003 | 300 |
| 11 | Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey | American Journal of Medicine | 2009 | 289 |
| 12 | Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference | Kidney International | 2016 | 289 |
| 13 | Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis | Circulation | 2015 | 268 |
| 14 | Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study | Lancet, The | 2020 | 265 |
| 15 | Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies | Kidney International | 2011 | 263 |
| 16 | Podocytopenia and disease severity in IgA nephropathy | Kidney International | 2002 | 262 |
| 17 | Chronic Kidney Disease and Cognitive Function in Older Adults: Findings from the Chronic Renal Insufficiency Cohort Cognitive Study | Journal of the American Geriatrics Society | 2010 | 258 |
| 18 | Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease | Intensive Care Medicine | 2011 | 254 |
| 19 | The Increasing Prevalence of Atrial Fibrillation among Hemodialysis Patients | Journal of the American Society of Nephrology: JASN | 2011 | 238 |
| 20 | Renal artery stenosis in kidney transplants | American Journal of Kidney Diseases | 1998 | 234 |
| 21 | Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy | Kidney International | 2012 | 232 |
| 22 | Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial | Lancet Respiratory Medicine,the | 2021 | 206 |
| 23 | Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy | Diabetes | 1990 | 203 |
| 24 | Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies | Toxins | 2016 | 197 |
| 25 | ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in Humans | Stroke | 2006 | 195 |
| 26 | A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction | Journal of the American Society of Nephrology: JASN | 2017 | 193 |
| 27 | Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease | Kidney International | 2021 | 192 |
| 28 | Increased Mortality Associated With Digoxin in Contemporary Patients With Atrial Fibrillation | Journal of the American College of Cardiology | 2014 | 190 |
| 29 | C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation | Transplantation | 2011 | 186 |
| 30 | Estimating the Risk of Radiocontrast-Associated Nephropathy | Journal of the American Society of Nephrology: JASN | 2017 | 185 |
| 31 | Cost of Acute Kidney Injury in Hospitalized Patients | Journal of Hospital Medicine | 2017 | 178 |
| 32 | Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial | Nephrology Dialysis Transplantation | 2020 | 177 |
| 33 | Intradialytic Hypotension and Vascular Access Thrombosis | Journal of the American Society of Nephrology: JASN | 2011 | 175 |
| 34 | Chimerism, Graft Survival, and Withdrawal of Immunosuppressive Drugs in HLA Matched and Mismatched Patients After Living Donor Kidney and Hematopoietic Cell Transplantation | American Journal of Transplantation | 2015 | 175 |
| 35 | Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States | American Journal of Kidney Diseases | 2021 | 175 |
| 36 | Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants | American Journal of Transplantation | 2012 | 172 |
| 37 | Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis | Kidney International | 2017 | 168 |
| 38 | Prevalence and Correlates of Cognitive Impairment in Hemodialysis Patients | Clinical Journal of the American Society of Nephrology: CJASN | 2010 | 163 |
| 39 | A Cost-Benefit Analysis of Government Compensation of Kidney Donors | American Journal of Transplantation | 2016 | 159 |
| 40 | Race, Genetic Ancestry, and Estimating Kidney Function in CKD | New England Journal of Medicine | 2021 | 159 |
| 41 | Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD | New England Journal of Medicine | 2021 | 155 |
| 42 | Infection Risk with Bolus versus Maintenance Iron Supplementation in Hemodialysis Patients | Journal of the American Society of Nephrology: JASN | 2013 | 148 |
| 43 | Vitamin D deficiency and frailty in older Americans | Journal of Internal Medicine | 2010 | 144 |
| 44 | Risk prediction models for contrast induced nephropathy: systematic review | BMJ, The | 2015 | 141 |
| 45 | Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial | Journals of Gerontology - Series A Biological Sciences and Medical Sciences | 2016 | 140 |
| 46 | Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference | Kidney International | 2020 | 140 |
| 47 | Melamine nephrotoxicity: an emerging epidemic in an era of globalization | Kidney International | 2009 | 135 |
| 48 | Association between Body Composition and Frailty among Prevalent Hemodialysis Patients | Journal of the American Society of Nephrology: JASN | 2014 | 135 |
| 49 | DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS | Journal of the American Society of Nephrology: JASN | 2018 | 135 |
| 50 | Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey | Nephrology Dialysis Transplantation | 2018 | 134 |
